UC San Diego’s new outpatient pavilion, which opened in March of this year, has been named the Koman Family Outpatient Clinic in tribute to Bill and Amy Koman and their family. The cancer research advocates have raised millions for the La Jolla campus’ medical facilities over the past 18 years.Their philanthropic efforts have focused on supporting collaborative cancer research at Moores Cancer Center at UC San Diego Health, Salk Institute, Sanford-Burnham Prebys Medical Center and Rady Children’s Hospital, San Diego and now the outpatient pavilion. The couple founded the Padres Pedal the Cause, an annual cycling event that raised $20 million between its inception in 2010 and 2016, according to an article in Ranch & Coast Magazine.Read More
Science Market Update
Tags: CA, University of California San Diego, new medical facility, San diego Biotech, Bioresearch product fair, San Diego, SDVS, UCSD, Research Funding, Biotechnology Vendor Showcase, laboratory equipment suppliers, new medical buildings, cancer reserach, 2018, life sciecne, san diego research, new science buildings
Researchers at the University of California San Diego School of Medicine are hopeful the combination of the experimental drug cirmtuzumab along with ibrutinub can halt the progression of chronic B-cell cancers. In an article published in the June 1 issue of Cell Stem Cell, researchers reported that treatment of 26 chronic leukemia patients with the experimental drug combination appeared to stop the disease’s progress.Read More
Tags: CA, University of California San Diego, San diego Biotech, Bioresearch product fair, San Diego, SDVS, UCSD, Research Funding, Biotechnology Vendor Showcase, laboratory equipment suppliers, cancer reserach, 2018, life sciecne, Blood Cancer, san diego research
UC San Diego has received federal support to continue its efforts to develop new treatments and, ultimately, find a cure for HIV/AIDS. A five-year, $15 million grant has been awarded to the university’s Center for AIDS Research by the National Institute of Allergy and Infectious Diseases (NIAID). The grant signals the federal agency’s support of the university’s research efforts that started in 1994, the height of the AIDS epidemic.Read More
Tags: CA, University of California San Diego, San diego Biotech, Bioresearch product fair, San Diego, SDVS, UCSD, Research Funding, Biotechnology Vendor Showcase, laboratory equipment suppliers, NIH grant, 2018, life sciecne, nih research funding, san diego research
UC San Diego life science researchers Don Cleveland and Joanne Chory were awarded 2018 Breakthrough Prize awards in December. Each winner receives $3,000,000, which makes the Breakthrough Prize among science’s largest award. The Breakthrough Prize is intended to highlight scientists who are tackling the biggest questions and toughest challenges in order to improve lives.
Dr. Cleveland, distinguished professor of cellular and molecular medicine, neurosciences and medicine at UC San Diego School of Medicine, was honored for his research of inherited neurodegenerative diseases such as ALS and Huntington’s. (Image courtesy of UCSD)
Dr. Chory, a plant biologist at Salk Institute and an adjunct professor in the Division of Biological Sciences at UC San Diego received her honors “for discovering how plants optimize their growth, development, and cellular structure to transform sunlight into chemical energy.”
Tags: CA, University of California San Diego, San diego Biotech, Bioresearch product fair, San Diego, SDVS, UCSD, Research Funding, Biotechnology Vendor Showcase, laboratory equipment suppliers, 2018, life sciecne, san diego research
Of the four main types of Leukemia, Acute Myeloid Leukemia (AML) diagnoses make up nearly one-third of new leukemia cases and is most likely to occur in adults. Although common cancer treatment methods are used for AML patients, only about half go into remission after chemotherapy treatments. Factors such as age and overall health contribute to these remission rates. Researchers at top life science institutions around the world continually study AML to gain better understandings of the biology of this cancer that can lead to new and more effect treatment methods. (Image courtesy Wikimedia Commons)Read More
Organ transplants are common surgeries that happen around the world. In the United States, more than 33,000 transplants occurred in 2016, with more than half of these being kidney transplants. Although the majority of people come out of transplant surgery with no problems, many develop serious infections caused by the common virus cytomegalovirus (CMV)when the immune system rejects the new kidney.Read More
A team of biochemists at UCLA have created a novel system of converting glucose into highly useful chemical compounds, such as those needed to create biofuels and pharmaceuticals. Previous research endeavors relied on using cells to convert sugar into desired compounds. This has been difficult to achieve because cells would rather use sugar for their own natural uses, such as building proteins and cell walls. The UCLA biochemists have recently developed a way to achieve the conversion of glucose into desired compounds- without using cells.Read More
The University of California, San Francisco is one of the most well-funded research institutions in the country, comprised of hundreds of life scientists conducting cutting-edge research who continuously publish important research results. Thanks to a generous donation, the university will be expanding its research space over the next few years.
(Image courtesy of Payton Chung via Wikimedia Commons)
Sandy and Joan Weill have recently announced a donation of $185 million to UCSF to create a new neuroscience institute on the UCSF Mission Bay campus, called the Weill Institute for Neurosciences. The institute will be housed in a soon-to-be-built $316 million facility, providing 270,000 square feet for research and outpatient services where medical practitioners and researchers can collaborate on projects.Read More
Tags: CA, Southwest, Neuroscience, SFVS, Biotechnology Vendor Showcase, UCSF, new Building, new funding, UC San Francisco Parnassus, funding news, 2016, Weill Institute for Neurosciences, Sandy and Joan Weill
A UCLA cancer research team has recently received a $7.6 million grant from the California Institute for Regenerative Medicine. This award will support research into genetically engineered white blood cells which can selectively target and kill tumor cells, while simultaneously activating other immune cells to do the same.Read More
When vital organs in the body, such as the lungs, begin to fail, an organ transplant can be a solution to the problem. However, receiving a transplant may have its own complications, such as the body rejecting its new organ.
Now, thanks to a generous donation of $1 million dollars from Michael and Linda Keston, researchers from the Division of Pulmonary and Critical Care Medicine at the UCLA David Geffen School of Medicine will be able to continue studying lung disease and the organ rejection commonly following a transplant.Read More